Professor in Pharmaceutical Nanotechnology (Click to view university profile)
Director in the Laboratory of Pharmaceutical Technology, Department of Pharmacy, National and Kapodistrian University of Athens
President of Hellenic Pharmaceutical Society (HPS)
Costas Demetzos is Professor of Pharmaceutical Nanotechnology in the National and Kapodistrian University of Athens. He serves as Director of the Laboratory of Pharmaceutical Technology and since 2008 he serves as President of the Hellenic Pharmaceutical Society (HPS). His research interest is primarily on Pharmaceutical Nanotechnology (lipidic, polymeric and mixed drug delivery nanosystems), Physical Pharmacy, Nanomedicine, Thermodynamics and Biophysics of nanoplatforms, Pharmaceutical Compounding and Regulatory Aspects. He has been awarded national and international patents, that have nanotechnological drug delivery systems, as their main object. He teaches in the Faculty of Pharmacy and the Faculty of Medicine of the National & Kapodistrian University of Athens, the courses of Pharmaceutical Nanotechnology and nano-Pharmacology, respectively, on undergraduate and postgraduate level. He has gained awards and honors for his contribution to the science of biomaterials and of pharmaceutical nanotechnology. He has published more than 300 research papers [h index 56), i10-index 194 (google scholar)], six monographs, he has co-authored one book and edited eight books. He has supervised more than 15 PhD students, 30 master’s students and more than 40 undergraduate Dissertations. His participation in the European COST programs helped in the mobility of his students and his lab members to Europe. He is the author of related University notes, textbooks, and monographs. He participates as a member of Scientific Organizing Committees and as a President of International and European scientific Conferences, while being an evaluator in many National and International committees. He was an elected member of the ExCo of EUFEPS (Network Coordinator) (2013-2016). At present, he is a member of the International Advisory Committee for Alzheimer’s disease (2019 - present), and of the Hellenic Initiative Against Alzheimer Disease (HIAAD) (2019- present). He is also a member of the editorial board of scientific journals serving as an expert in the field of pharmaceutical nanotechnology. In 2018 Costas Demetzos, was honored with an award by the Order of Sciences of the Academy of Athens for his scientific achievements in Pharmaceutical Nanotechnology and for his monograph ‘Pharmaceutical Nanotechnology. Fundamentals and Practical Applications’, Springer, 2016. In 2021, Prof. Demetzos has been elected as an Ordinary member in Class IV-Natural Sciences of the European Academy of Sciences and Arts (Academia Scientiarium et Artium Europaea). Since 2023 he acts as Associate Editor of the prestigious International Journal on nanotechnology, Journal of Liposome Research (JLR). In 2024, he will be awarded by the National and Kapodistrian University of Athens with the excellence of the outstanding University teaching of the Faculty of Health Sciences as a distinguished professor.
Adjunct Assistant Professor, Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Poland
Nikolaos Naziris is a graduate of Pharmacy, MSc in "Industrial Pharmacy", PhD in Pharmaceutical Technology and post-doctoral researcher at the National and Kapodistrian University of Athens from 2019 to 2021. Since 2020, he has been manager of research and development and quality control at the company In Touch Health, Doctor’s Formulas, with which he is still a partner. He currently serves as an Assistant Professor at the University of Lodz in Poland. His PhD thesis, entitled “Pharmaceutical Nanotechnology. Design and Evaluation of Stimuli-responsive Chimeric Nanocarriers”, was funded by the 1st scholarship of the Hellenic Foundation for Research and Innovation (HFRI) for PhD students. His research interests include the design, development, and study of stimuli-responsive chimeric drug nanocarriers, aiming to cure various types of cancer and other complex diseases. Additionally, he is a regular member of the Hellenic Pharmaceutical Society (HPS). He has 29 published papers in peer-reviewed journals, including 4 review papers, 5 book chapters, as well as 12 oral and around 20 poster presentations in international and national conferences. His research interests are oriented in the design, development and study of stimuli-responsive chimeric/mixed nanocarriers, primarily liposomes, with the purpose of curing various types of cancer and other types of difficult diseases.
Maria Chountoulesi (Pharmacist, MSc., PhD) graduated in 2015 from the Department of Pharmacy, of National and Kapodistrian University of Athens (NKUA) with grade Excellent 8.69/10. Subsequently in 2017, she received her master degree (M.Sc.) in “Industrial Pharmacy”, from the Department of Pharmacy, of NKUA, with grade Excellent 9.63/10. In 2020, she completed her PhD studies in the Department of Pharmacy, of NKUA, with grade Excellent, under the supervision of the expert of Pharmaceutical Nanotechnology Prof. Costas Demetzos. Her PhD Thesis entitled “Development and evaluation of lyotropic liquid crystalline nanosystems intended for the delivery of active pharmaceutical ingredients to subcellular organelles” was awarded by PhD Scholarship, implemented by the State Scholarships Foundation (IKY), co-financed by Greece and the European Union (European Social Fund-ESF) (MIS-5000432). In 2019, she also received an Erasmus+ Traineeship Fellowship. She has already published 14 papers in peer-reviewed international journals and 4 chapters in scientific books and has also presented 22 presentations (posters and oral) in international and national conferences. Her research interests focus on pharmaceutical nanotechnology, namely design, development, as well as evaluation of drug delivery nanosystems.
Chrysostomou Varvara received a bachelor’s degree in Material Science in 2015 from the Department of Materials Science of the University of Patras and a master’s degree in “Polymer Science and Applications” in 2017 from the Department of Chemistry of the National and Kapodistrian University of Athens. In 2024, she completed her PhD studies in the Department of Pharmacy of NKYA under the guidance of the expert of Pharmaceutical Nanotechnology, Professor Costas Demetzos. Her PhD Thesis entitled "Pharmaceutical Nanotechnology: Design and Developments of Nanocarriers for Gene Therapy" was funded by the scholarship of the Hellenic Foundation for Research and Innovation (HFRI) for PhD students. Her research interest is focused on Pharmaceutical Nanotechnology and the development of advanced nanosystems (e.g. liposomes, polymeric micelles, magnetic nanoparticles) for drug and gene delivery in order to generate new perspectives on disease treatment. To date she has published 3 papers in peer-reviewed international journals and presented 9 posters and oral communications in international and national conferences.
Maria Tsakiri completed her degree in Pharmacy, with specialisation in Pharmaceutical Technology, at National and Kapodistrian University of Athens (NKUA), Greece, in 2019. Following this, in 2020 she received her Master degree (M.Sc.) in Nanomedicine from the School of Medicine at NKUA. During her Master studies, she focused on the evaluation of nanoscale antigen delivery systems for the development of safe and effective vaccines against infectious diseases. Until now she has been a PhD at the Department of Pharmacy, NKUA, under the supervision of Prof. Costas Demetzos. Her current interests lie in the development of biomimetic drug and/or biomolecule delivery nanosystems that target human brain cells.
Ioannis Tsichlis holds a Diploma in Pharmacy from the University of Patras (UOP) and an MSc in Nanomedicine from the National and Kapodistrian University of Athens (NKUA). During his undergraduate studies, he focused on designing and studying liposomal lidocaine for topical delivery. Continuing his academic endeavors, he completed his master’s thesis in the Laboratory of Pharmaceutical Nanotechnology, under the guidance of the expert in the field Professor Costas Demetzos. His master’s thesis was focused on the development of liposomes modified with non-ionic surfactants for quercetin delivery. Since January, 2023, he has been a PhD student in Pharmaceutical Nanotechnology. His research lies in the development, physicochemical characterization, and biological evaluation of hybrid nanosystems for gene therapy. His ultimate goal is to develop safe and effective gene delivery vehicles for the treatment of serious disorders.
HellasSites